can ghk-cu cause cancer does promote growth GHK-Cu Peptide Therapy: The Definitive

13,6,7 The initial laboratory assessment of a patient with suspected vitamin B 12 deficiency should include a complete blood count and a serum vitamin B 12 level

Frenette, E., Lui, A

Additionally, it is unknown whether senolytic FOXO4-DRI can be used to treat keloids

(4) Baar MP, Brandt RMC, Putavet DA, Klein JDD, Derks KWJ, Bourgeois BRM, Stryeck S, Rijksen Y, van Willigenburg H, Feijtel DA, van der Pluijm I, Essers J, van Cappellen WA, van IJcken WF, Houtsmuller AB, Pothof J, de Bruin RWF, Madl T, Hoeijmakers JHJ, Campisi J, de Keizer PLJ

A common vial contains 50 mg GHK-Cu, 10 mg BPC-157, and 10 mg TB-500 (70 mg total), but the ratios are not standardized

While animal and in vitro studies have examined its activity, large-scale human clinical trials are limited, and its full safety and efficacy profile has not been established